MARIMO cells harbor a CALR mutation but are not dependent on JAK2/STAT5 signaling

被引：31
作者：
Kollmann, K. [1 ,2 ]
Nangalia, J. [1 ,2 ,3 ,4 ]
Warsch, W. [1 ,2 ]
Quentmeier, H. [5 ]
Bench, A. [4 ]
Boyd, E. [4 ]
Scott, M. [4 ]
Drexler, H. G. [5 ]
Green, A. R. [1 ,2 ,4 ]
机构：
[1] Univ Cambridge, Wellcome Trust MRC Stem Cell Inst, Cambridge Inst Med Res, Cambridge, England
[2] Univ Cambridge, Dept Haematol, Cambridge, England
[3] Wellcome Trust Sanger Inst, Cambridge, England
[4] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England
[5] German Collect Microorganisms & Cell Cultures, Leibniz Inst DSMZ, Braunschweig, Germany
来源：
LEUKEMIA | 2015年 / 29卷 / 02期
关键词：
MYELOPROLIFERATIVE NEOPLASMS; ESSENTIAL THROMBOCYTHEMIA; MYELOFIBROSIS; RETICULUM; JAK2; CALRETICULIN; INHIBITOR;
D O I：
10.1038/leu.2014.285
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：494 / 497
页数：5
相关论文
共 50 条
  • [31] Coexistence of JAK2 or CALR mutation is a rare but clinically important event in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors
    Lewandowski, K.
    Gniot, M.
    Wojtaszewska, M.
    Kandula, Z.
    Becht, R.
    Paczkowska, E.
    Medras, E.
    Wasilewska, E.
    Iwola, M.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2018, 40 (03) : 366 - 371
  • [32] CD24+ Ovarian Cancer Cells Are Enriched for Cancer-Initiating Cells and Dependent on JAK2 Signaling for Growth and Metastasis
    Burgos-Ojeda, Daniela
    Wu, Rong
    McLean, Karen
    Chen, Yu-Chih
    Talpaz, Moshe
    Yoon, Euisik
    Cho, Kathleen R.
    Buckanovich, Ronald J.
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (07) : 1717 - 1727
  • [33] A CK2-dependent mechanism for activation of the JAK-STAT signaling pathway
    Zheng, Ying
    Qin, Hongwei
    Frank, Stuart J.
    Deng, Luqin
    Litchfield, David W.
    Tefferi, Ayalew
    Pardanani, Animesh
    Lin, Fang-Tsyr
    Li, Jingzhi
    Sha, Bingdong
    Benveniste, Etty N.
    BLOOD, 2011, 118 (01) : 156 - 166
  • [34] The JAK-STAT signaling pathway is differentially activated in CALR-positive compared with JAK2V617F-positive ET patients
    Lau, Winnie W. Y.
    Hannah, Rebecca
    Green, Anthony R.
    Goettgens, Bertie
    BLOOD, 2015, 125 (10) : 1679 - 1681
  • [35] The Clinical Characteristics and Outcomes of JAK2/ CALR/MPL Mutation Related Myeloproliferative Neoplasms- A Single Centre Study from Malaysia
    Baizura, Z. Nur
    Cheong, C. S.
    Anuar, A.
    Nadarajan, V. S.
    Bee, P. C.
    Chin, E. F. M.
    Khairullah, S.
    Liong, C. C.
    Zamri, Y.
    Gan, G. G.
    IIUM MEDICAL JOURNAL MALAYSIA, 2025, 24 (01): : 49 - 56
  • [36] CALR, JAK2, and MPL Mutation Profiles in Patients With Four Different Subtypes of Myeloproliferative Neoplasms Primary Myelofibrosis, Essential Thrombocythemia, Polycythemia Vera, and Myeloproliferative Neoplasm, Unclassifiable
    Kim, Seon Young
    Im, Kyongok
    Park, Si Nae
    Kwon, Jiseok
    Kim, Jung-Ah
    Lee, Dong Soon
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 143 (05) : 635 - 644
  • [37] JAK2V617F mutation in platelets from essential thrombocythemia patients:: correlation with clinical features and analysis of STAT5 phosphorylation status
    Heller, Paula G.
    Lev, Paola R.
    Salim, Juan P.
    Kornblihtt, Laura I.
    Goette, Nora P.
    Chazarreta, Carlos D.
    Glembotsky, Ana C.
    Vassallu, Patricia S.
    Marta, Rosana F.
    Molinas, Felisa C.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2006, 77 (03) : 210 - 216
  • [38] BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia
    Hantschel, Oliver
    Warsch, Wolfgang
    Eckelhart, Eva
    Kaupe, Ines
    Grebien, Florian
    Wagner, Kay-Uwe
    Superti-Furga, Giulio
    Sexl, Veronika
    NATURE CHEMICAL BIOLOGY, 2012, 8 (03) : 285 - 293
  • [39] Resveratrol selectively induces apoptosis in malignant cells with the JAK2V617F mutation by inhibiting the JAK2 pathway
    Ly Quoc Trung
    Espinoza, J. Luis
    An, Dao T.
    Nguyen Hoang Viet
    Shimoda, Kazuya
    Nakao, Shinji
    MOLECULAR NUTRITION & FOOD RESEARCH, 2015, 59 (11) : 2143 - 2154
  • [40] Constitutive STAT5 phosphorylation in CD34+ cells of patients with primary myelofibrosis: Correlation with driver mutation status and disease severity
    Abba, Carlotta
    Campanelli, Rita
    Catarsi, Paolo
    Villani, Laura
    Abbonante, Vittorio
    Sesta, Melanie Antonietta
    Barosi, Giovanni
    Rosti, Vittorio
    Massa, Margherita
    PLOS ONE, 2019, 14 (08):
12345